Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Taylor Ben RChief Financial Officer |  RXRXRECURSION PHARMACEUTICALS, INC.Tax withholding | F | $149K 48.0K sh | Apr 8, 2026 |
| 8 | Beer Michael ThomasChief Financial Officer |  NRGVEnergy Vault Holdings, Inc.Option exercise | M | $59K 50.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 8 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Open-market sale · 10b5-1 plan | SELL | $180K 3,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 8 | Katz ZacharyCLO and Head of Global Affairs |  GRNDGrindr Inc.Tax withholding | F | $122K 10.1K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 8 | Balance Austin JChief Product Officer | GRNDGrindr Inc. Tax withholding | F | $163K 13.4K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 7 | Cannestra AnthonyDirector |  BZAIBlaize Holdings, Inc.Option exercise · 10b5-1 plan | M | — 50.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 6 | Brown ShellyEVP, Chief Strategy Officer | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $38K 900 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Feierstein Matthew DavidPresident |  EVCMEverCommerce Inc.Open-market sale · 10b5-1 plan | SELL | $119K 10.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 6 | Feierstein Matthew DavidPresident | EVCMEverCommerce Inc. Open-market sale · 10b5-1 plan | SELL | $57K 5,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $198K 3,900 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 6 | Gibson ChristopherDirector | RXRXRECURSION PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $124K 40.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 5 | Porter James RichardDirector, President and CEO |  NUVLNuvalent, Inc.Option exercise · 10b5-1 plan | M | $260K 13.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 5 | Tessari EbenCHIEF STRATEGY OFFICER |  KNSAKiniksa Pharmaceuticals International, plcTax withholding | F | $41K 846 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 5 | Tessari EbenCHIEF STRATEGY OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise | M | — 2,726 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 5 | Lin MarkEVP and CFO |  SMTCSEMTECH CORPGrant or award | A | — 450 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 5 | Porter James RichardDirector, President and CEO | NUVLNuvalent, Inc. Option exercise · 10b5-1 plan | M | $454K 16.3K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 5 | Ragosa MarkCHIEF FINANCIAL OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise | M | — 2,694 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 4 | Prahm JeremyChief Investment Officer |  FOAFinance of America Companies Inc.Open-market sale · 10b5-1 plan | SELL | $93K 5,228 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 4 | Allison JonathanChief Administrative Officer |  ROOTRoot, Inc.Open-market sale · 10b5-1 plan | SELL | $76K 1,706 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 3 | Porter James RichardDirector, President and CEO | NUVLNuvalent, Inc. Option exercise · 10b5-1 plan | M | — 16.3K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 3 | Porter James RichardDirector, President and CEO | NUVLNuvalent, Inc. Option exercise · 10b5-1 plan | M | — 13.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 3 | Choudary Kiran KumarChief Financial Officer | RBRKRubrik, Inc. Open-market sale · 10b5-1 plan | SELL | $48K 900 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 3 | Moat RossCHIEF OPERATING OFFICER | KNSAKiniksa Pharmaceuticals International, plc Option exercise · 10b5-1 plan | M | — 2,477 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 2 | Cowan ElviaSVP, Finance & CAO | PCVXVaxcyte, Inc. Option exercise · 10b5-1 plan | M | $78K 3,000 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | $107K 14.7K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 |  Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 6,250 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Option exercise · 10b5-1 plan | M | — 14.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Gibson ChristopherDirector | RXRXRECURSION PHARMACEUTICALS, INC. Derivative conversion · 10b5-1 plan | C | — 40.0K sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | NETCloudflare, Inc. Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Apr 8, 2026 traded Apr 8, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 16.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 225.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 27.1K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 |  Tenev VladimirDirector, Chief Executive Officer | HOODRobinhood Markets, Inc. Derivative conversion · 10b5-1 plan | C | — 375.0K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 0 | Date Rajeev VDirector | CRCLCircle Internet Group, Inc. Option exercise · 10b5-1 plan | M | $102 1,273 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 0 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Derivative conversion · 10b5-1 plan | C | — 27.1K sh | Apr 8, 2026 traded Apr 6, 2026 |